[go: up one dir, main page]

ZA200610780B - Fused heterocyclic kinase inhibitors - Google Patents

Fused heterocyclic kinase inhibitors

Info

Publication number
ZA200610780B
ZA200610780B ZA200610780A ZA200610780A ZA200610780B ZA 200610780 B ZA200610780 B ZA 200610780B ZA 200610780 A ZA200610780 A ZA 200610780A ZA 200610780 A ZA200610780 A ZA 200610780A ZA 200610780 B ZA200610780 B ZA 200610780B
Authority
ZA
South Africa
Prior art keywords
kinase inhibitors
fused heterocyclic
heterocyclic kinase
fused
inhibitors
Prior art date
Application number
ZA200610780A
Inventor
Robert M Borzilleri
Tram N Huynh
Chen Xiao Tao
Cai Zhen-Wei
Chen Zhong
Vaccaro Wayne
Kyoung S Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA200610780B publication Critical patent/ZA200610780B/en

Links

ZA200610780A 2004-06-28 2006-12-20 Fused heterocyclic kinase inhibitors ZA200610780B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58345904P 2004-06-28 2004-06-28

Publications (1)

Publication Number Publication Date
ZA200610780B true ZA200610780B (en) 2008-11-26

Family

ID=38214881

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610780A ZA200610780B (en) 2004-06-28 2006-12-20 Fused heterocyclic kinase inhibitors

Country Status (2)

Country Link
CN (3) CN101005843A (en)
ZA (1) ZA200610780B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5592890B2 (en) * 2008-10-08 2014-09-17 ブリストル−マイヤーズ スクイブ カンパニー Pyrrolotriazine kinase inhibitor
WO2012100135A1 (en) * 2011-01-21 2012-07-26 Abbott Laboratories Picolinamide inhibitors of kinases
FR3008092B1 (en) * 2013-07-02 2015-07-31 Arkema France PROCESS FOR SYNTHESIZING AZO COMPOUNDS
KR101598664B1 (en) * 2013-09-04 2016-03-02 씨제이헬스케어 주식회사 Protein kinase inhibitors comprising a pyrrolopyridazine derivative
CN103848838A (en) * 2014-01-23 2014-06-11 中国药科大学 c-Met-VEGFR-2 double antagonist, preparation method and medical use thereof
US10654808B2 (en) 2015-04-07 2020-05-19 Guangdong Raynovent Biotech Co., Ltd. Tyrosine kinase inhibitor and pharmaceutical composition comprising same
CN106279147A (en) * 2015-05-21 2017-01-04 中国科学院上海药物研究所 A kind of pyrido nitrogen heterocyclic and its production and use
CN105732616B (en) * 2016-01-08 2018-07-27 江西科技师范大学 Pyrrolopyridines of the amide structure containing biaryl and its preparation method and application
CN106831824A (en) * 2016-12-28 2017-06-13 江西科技师范大学 Pyrrolopyridines and its application containing naphthyridones structure
WO2018233526A1 (en) * 2017-06-19 2018-12-27 上海和誉生物医药科技有限公司 CSF1R inhibitor and preparation method and application thereof
WO2019080723A1 (en) * 2017-10-26 2019-05-02 北京越之康泰生物医药科技有限公司 Polysubstituted pyridone derivative, preparation method therefor and medical use thereof
CN109942544B (en) * 2017-12-21 2021-06-11 中国科学院合肥物质科学研究院 Novel indazole derivative kinase inhibitor
WO2020042618A1 (en) * 2018-08-27 2020-03-05 北京越之康泰生物医药科技有限公司 Multi-substituted pyridone derivatives and medical use thereof
CN110330479A (en) * 2019-07-19 2019-10-15 南京华威医药科技集团有限公司 A kind of antitumoral compounds and application thereof as AXL inhibitor
CN113880845A (en) * 2021-10-13 2022-01-04 广州六顺生物科技股份有限公司 Pyrrolotriazine derivatives, and preparation method and application thereof
WO2023125803A1 (en) 2021-12-29 2023-07-06 北京鞍石生物科技有限责任公司 Heteroaromatic nitrogen-oxide compound, preparation method therefor, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230302B1 (en) * 2000-10-20 2015-12-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds and pharmaceutical compositions containing them
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases

Also Published As

Publication number Publication date
CN101005843A (en) 2007-07-25
CN1993130A (en) 2007-07-04
CN101027305A (en) 2007-08-29
CN1993130B (en) 2010-06-23
CN100577663C (en) 2010-01-06

Similar Documents

Publication Publication Date Title
IL180325A0 (en) Fused heterocyclic kinase inhibitors
EP1794137A4 (en) Specific kinase inhibitors
IL179414A0 (en) Fused heterocyclic compound
GB2424882B (en) Selective kinase inhibitors
IL183276A0 (en) Kinase inhibitors
IL177278A0 (en) Pyrazolotriazines as kinase inhibitors
EP1968950A4 (en) Pyrimidine kinase inhibitors
IL190078A0 (en) Kinase inhibitors
IL180587A0 (en) Heterocyclic compounds
IL186407A0 (en) Fused heterocyclic compounds
IL192298A0 (en) Heterocyclic janus kinase 3 inhibitors
IL189374A0 (en) FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS
ZA200710343B (en) Bicyclic derivatives as p38 kinase inhibitors
ZA200709269B (en) Protein kinase inhibitors
EP2222166A4 (en) Heterocyclic kinase inhibitors
PL378116A1 (en) Heterocyclic kinase inhibitors
IL188027A0 (en) Bicyclic derivatives as p38 kinase inhibitors
IL183647A (en) 3-ethylidenehydrazino substituted heterocyclic compounds
ZA200610780B (en) Fused heterocyclic kinase inhibitors
SI1943243T1 (en) Kinase inhibitors
EP1737446A4 (en) Fused heterocyclic compounds
ZA200607648B (en) Kinase inhibitors
EP1968581A4 (en) Tetracyclic kinase inhibitors
ZA200608775B (en) Monocyclic heterocycles as kinase inhibitors
ZA200703835B (en) Heterocyclic substituted bisarylurea derivatives as kinase inhibitors